Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €148.49 EUR
Change Today +2.36 / 1.61%
Volume 7.0
UTH On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:54 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for united therapeutics corp (UTH)

Year over year, United Therapeutics Corporation has been able to grow revenues from $1.1B USD to $1.3B USD. Most impressively, the company has been able to reduce the percentage of sales devoted to selling, general and administrative costs from 35.59% to 29.80%. This was a driver that led to a bottom line growth from $174.6M USD to $340.1M USD.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Reclassified
Dec 31
2013
Reclassified
Dec 31
2014
4 Year
Trend
Revenues741.1906.11,106.91,279.5
Other Revenues2.110.010.09.0
TOTAL REVENUES743.2916.11,117.01,288.5
Cost of Goods Sold88.9119.3131.1125.9
GROSS PROFIT654.3796.8985.91,162.6
Selling General & Admin Expenses, Total156.5194.9394.0381.3
R&D Expenses175.0173.4299.3242.5
OTHER OPERATING EXPENSES, TOTAL331.5368.3693.4623.8
OPERATING INCOME322.8428.5292.5538.8
Interest Expense-21.4-16.6-18.1-17.6
Interest and Investment Income3.5------
NET INTEREST EXPENSE-17.9-16.6-18.1-17.6
Other Non-Operating Income (Expenses)-0.74.74.54.0
EBT, EXCLUDING UNUSUAL ITEMS304.1416.5278.9525.2
Other Unusual Items, Total-5.024.2----
Insurance Settlements--31.0----
Other Unusual Items-5.0------
EBT, INCLUDING UNUSUAL ITEMS299.1440.7278.9525.2
Income Tax Expense81.9136.2104.3185.1
Earnings from Continuing Operations217.2304.4174.6340.1
EARNINGS FROM DISCOUNTINUED OPERATIONS0.6------
NET INCOME217.9304.4174.6340.1
NET INCOME TO COMMON INCLUDING EXTRA ITEMS217.9304.4174.6340.1
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS217.2304.4174.6340.1
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTH:GR €148.49 EUR +2.36

UTH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actelion Ltd SFr.112.60 CHF -0.10
Alexion Pharmaceuticals Inc $181.65 USD -4.14
Celanese Corp $57.62 USD -0.85
Nippon Shinyaku Co Ltd ¥4,390 JPY -20.00
Vertex Pharmaceuticals Inc $126.34 USD -0.62
View Industry Companies
 

Industry Analysis

UTH

Industry Average

Valuation UTH Industry Range
Price/Earnings 25.7x
Price/Sales 5.9x
Price/Book 6.1x
Price/Cash Flow 22.1x
TEV/Sales 5.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.